Literature DB >> 10929746

Extraskeletal mesenchymal chondrosarcoma involving the heart: report of a case.

G Nesi1, E Pedemonte, F Gori.   

Abstract

Extraskeletal mesenchymal chondrosarcoma is a rare tumor frequently arising in the meninges and lower limbs. We describe a case of mesenchymal chondrosarcoma involving the heart in a 39-year-old man who presented with fever, chest pain and shortness of breath. His clinical course was rapid, leaving insufficient time for a complete diagnostic work-up, and the patient died 2 months after the onset of symptoms.

Entities:  

Mesh:

Year:  2000        PMID: 10929746

Source DB:  PubMed          Journal:  Ital Heart J        ISSN: 1129-471X


  5 in total

1.  Radiofrequency ablation of metastatic chondrosarcoma-associated refractory ventricular tachycardia originating from the right ventricular outflow tract: A case report and literature review.

Authors:  Xiangmin Shi; Zhuo Liang; Jian Li; Jianping Guo; Zhaoliang Shan; Yutang Wang
Journal:  Exp Ther Med       Date:  2016-07-15       Impact factor: 2.447

2.  A fatal case of primary cardiac chondrosarcoma presenting with amaurosis fugax.

Authors:  Jens Sundbøll; Nils Henrik Stubkjær Hansson; Steen Baerentzen; Manan Pareek
Journal:  BMJ Case Rep       Date:  2015-10-05

3.  Primary extraskeletal chondroblastic osteosarcoma of the pericardium: a case report and literature review.

Authors:  Qianqian Wang; Xiaojie Wang; Qing Zhu; Xinghua Gu; Peng Gao; Yuguo Chen; Xiaojuan Wu; Chuanbao Li
Journal:  Eur Heart J Case Rep       Date:  2020-05-15

4.  Extraskeletal mesenchymal chondrosarcoma of the heart responded to systemic chemotherapy: a case report.

Authors:  Chien Ter Hsing; Sung Yong Oh; Suee Lee; Hyuk-Chan Kwon; Sung-Hyun Kim; Tae-Ho Park; Jong Soo Woo; Seo Hee Na; Hyo-Jin Kim
Journal:  Cancer Res Treat       Date:  2007-09-30       Impact factor: 4.679

Review 5.  Mesenchymal chondrosarcoma of bone and soft tissue: a systematic review of 107 patients in the past 20 years.

Authors:  Jie Xu; Dasen Li; Lu Xie; Shun Tang; Wei Guo
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.